The Difference Between Basal Cell Carcinoma and Squamous Cell Carcinoma

BCC starts in basal cells, which sit in the deeper part of the outer layer of the skin. SCC starts in squamous cells, which are closer to the surface.

The simple way to think about it is this: BCC is the most common, and it very rarely spreads, but it can still cause local damage if it is left to grow.

SCC is also very treatable, but it is more likely to spread than BCC, which is why clinicians often take a more cautious approach with staging and follow-up.

Where Does Carcinoma Start?

It helps to picture the skin as layers, with the epidermis on top. Basal cells sit at the bottom of that outer layer, where new skin cells are produced. Squamous cells sit higher up and form much of the visible surface. When cancer starts in a different cell type, it tends to grow in a different pattern, which is why the names matter.

BCC often grows in a slow, persistent way, sometimes travelling downwards into deeper tissue as time goes by. SCC can also grow slowly, but it is more likely than BCC to behave in a way that makes clinicians and private oncologists think about spread risk and staging.

Neither cancer should be judged on appearance alone, because early lesions can look deceptively minor. The sensible goal is to identify what it is before it has the chance to become a bigger problem.

What Does Basal Cell Carcinoma Look Like?

BCC often appears as a pearl-like bump, a flesh-coloured growth, or a pink patch that does not settle. Some people notice a sore that crusts, bleeds, then returns, which gets written off as a “spot that keeps catching”.

On the face, it can look like a shiny, slightly raised area that seems out of place compared with the surrounding skin. If something keeps reappearing in the same area, that pattern matters.

These lesions are common on sun-exposed areas such as the face, scalp, neck, and ears, but they can appear anywhere. People sometimes mistake BCC for eczema, a scar, or a patch of dry skin that needs a better moisturiser.

The consequence of waiting is not usually spread to distant organs, but deeper local growth that can make treatment more involved. The practical point is that persistent change is a reason to get it checked, even if it does not hurt.

What Does Squamous Cell Carcinoma Look Like?

SCC often looks like a scaly red patch, a firm red bump, or a thickened area that feels rough compared with nearby skin. It can also appear as a sore that does not heal, or an ulcerated area that bleeds more easily than you would expect.

Some SCCs become tender or painful, which can be a clue that the lesion is more than simple irritation. A growth that hardens, thickens, or breaks down over time deserves proper assessment.

SCC is often found on sun-exposed areas such as the rim of the ear, face, neck, arms, chest, and back. It can start in areas of sun damage, and it may develop from actinic keratoses (AKs), which are precancerous scaly patches caused by UV exposure. In people with darker skin tones, SCC can also appear on less sun-exposed areas, so location alone is not a reliable guide.

The key point is that SCC tends to trigger a more cautious approach because of its spread potential.

What Risk Factors Do They Share?

BCC and SCC share many of the same risk factors, with UV exposure sitting at the top of the list. That includes long-term sun exposure and sunbeds, plus a history of repeated sunburns, especially earlier in life.

People with fair skin are at higher risk, but neither cancer is exclusive to one skin type. A weakened immune system can also increase risk, which is important for anyone who has had an organ transplant or takes immunosuppressant medication.

The risk picture is usually cumulative rather than dramatic, which is why people can be surprised by a diagnosis. Someone who “never sunbathes” can still build up years of incidental exposure through work, commuting, sport, or holidays. A personal history of skin cancer also raises the chance of developing another lesion later, so follow-up matters.

If you have several risk factors, a new persistent mark should be treated as information, not noise.

Why Do Doctors Take SCC More Seriously?

BCC rarely spreads to other parts of the body, but it can still be destructive if it grows into deeper layers. Left untreated, it can involve nerves, cartilage, and bone, particularly on the face, where structures sit close together. That is why early BCC treatment is not only about “getting rid of it” but also about avoiding preventable damage.

A small lesion addressed early often means a smaller procedure and a cleaner cosmetic result.

SCC has a higher chance of spread than BCC, even though spread remains uncommon overall. When SCC does spread, it tends to involve nearby lymph nodes first, which is why clinicians pay attention to features like size, depth, and high-risk locations. This difference influences how urgent the work-up feels and how wide the treatment margins may need to be.

In plain terms, SCC is more likely to prompt a discussion about staging and longer-term follow-up.

Why Is a Biopsy Needed?

It is tempting to rely on a photograph, a mirror check, or a best guess based on a description online. The problem is that early BCC and SCC can overlap in appearance, and harmless lesions can mimic both. A clinician will look at the lesion, ask about how long it has been there, and check for other signs of sun damage.

That first assessment is useful, but it does not replace confirmation.

A biopsy is usually the step that provides certainty, because it allows a pathologist to identify the cell type and key features under a microscope. The report can also comment on depth and whether the cells look more or less aggressive, which supports decision-making.

In private care, people often value quicker access to biopsy and results, because it shortens the period of uncertainty. The practical benefit is a clearer plan with fewer assumptions.

How Do the Two Differ?

Staging describes how far a cancer has grown or spread, and it depends on the type. Some sources note that most BCCs do not need staging because spread is very rare, unless the cancer is very large. SCC is more likely to be staged because SCC can spread, even though it is still uncommon, and staging helps guide whether the focus stays local or extends to lymph node assessment. That is one reason SCC consultations often include a broader check of the surrounding area.

It also helps to know that Stage 0 is called carcinoma in situ, which means the cells have started turning into cancer but have not spread into nearby tissue. Squamous cell carcinoma in situ is also called Bowen’s disease, and it may develop into SCC without treatment. Grading is different from staging and refers to how abnormal the cells look under a microscope, with grade 1 looking more like normal cells and grade 3 looking more abnormal. In private treatment settings, the medical definitions stay the same, but faster access to imaging and treatment booking can make the pathway feel more straightforward.

What Are the Treatment Options?

For both BCC and SCC, surgery is often the main treatment, especially when the goal is to remove the cancer completely in one step. Options include standard excision and, in selected cases, curettage. Mohs surgery is commonly used for lesions in sensitive areas such as the face, scalp, and neck, because it aims to remove the cancer while sparing as much healthy tissue as possible. The best approach depends on the site, size, and subtype, not just the name of the cancer.

Treatment choices can differ because SCC may require a wider safety margin or closer follow-up, depending on risk features. Non-surgical treatments can also be appropriate in certain situations, especially for superficial lesions or when surgery would cause unwanted functional or cosmetic impact. The key point is that “treatable” does not mean any kind of treatment is suitable, and the plan should match the biology of the lesion. A tailored approach reduces recurrence risk and limits unnecessary intervention.

Radiotherapy and Other Non-surgical Treatments

Radiotherapy can be a highly effective treatment for non-melanoma skin cancer, particularly for people who are not suitable for surgery or for lesions in areas where surgery would be difficult. It may also be chosen when the aim is to preserve appearance and function in delicate facial sites, depending on the case.

Other local treatments may include photodynamic therapy (PDT) for selected superficial lesions, as well as topical treatments such as 5-fluorouracil cream (often known as Efudix) or imiquimod for suitable early or superficial disease.

Cryotherapy is commonly used for AKs and may be used for selected superficial changes, depending on clinical judgment. These options are not interchangeable, and they are chosen based on depth, location, and the certainty of diagnosis. The practical advantage of discussing options is that you can balance cure rates, scarring, treatment time, and follow-up in a way that fits your situation.

When to Get Checked

A useful rule is to pay attention to persistence and change, not just how something looks on a single day. A sore that does not heal, a lesion that bleeds with minimal trauma, or a scaly patch that keeps returning in the same place should be assessed. Growth, thickening, crusting, and ulceration are also meaningful changes, particularly on high-risk sites such as the ears, lips, and around the eyes. These patterns matter because they suggest ongoing abnormal behaviour in the skin.

If you are immunosuppressed or have a history of skin cancer, the threshold for review should be lower because the risk profile changes. It also helps to remember that skin cancers can occur anywhere, including areas that do not see much sun, so reassurance based on location can be misleading.

Photographs can be helpful for tracking change over weeks, but they should support a clinical assessment rather than replace it. The consequence of acting early is often a simpler treatment plan and a clearer outcome.

The Simplest Way to Remember the Difference

If you want a simple way to hold it in your head, focus on the behaviour rather than memorising every possible appearance. BCC is usually slow and very unlikely to spread, but it can cause deep local damage if ignored. SCC is also very treatable, but it is more likely to spread than BCC, so it often leads to closer follow-up and staging conversations. Both are linked to UV exposure, so prevention and early detection remain central.

• BCC: most common, rarely spreads, can grow deep locally
• SCC: second most common, higher spread risk than BCC, more often staged
• Both: confirmed by biopsy, treated effectively when identified early

Understanding the Difference, Acting on Change

The difference between BCC and SCC is not just a textbook detail, because it influences urgency, staging, treatment choice, and follow-up.

Most people do very well with treatment, especially when the lesion is identified before it has had time to grow into deeper tissue or involve lymph nodes. If something on the skin persists, changes, or breaks down, getting a proper assessment turns uncertainty into a plan.

That clarity is often the biggest relief, and it usually leads to the most straightforward care pathway.

About Dr James Wilson

Dr James Wilson is a consultant oncologist based in Central London, with a specialist focus on lung and skin cancer, as well as advanced treatments such as proton beam therapy and stereotactic radiotherapy. Through his private practice, he offers prompt diagnosis, structured treatment planning, and calm, practical guidance during challenging stages of care.